Boston Scientific Corp. Company Profile (NYSE:BSX)

About Boston Scientific Corp.

Boston Scientific Corp. logoBoston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and PI businesses. Its Rhythm Management segment consists of CRM and EP businesses. Its MedSurg segment consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its interventional cardiology products include Drug-Eluting Coronary Stent Systems, Core Coronary Technology, Intravascular Imaging and Structural Heart Therapy. Its peripheral products include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BSX
  • CUSIP: 10113710
Key Metrics:
  • Previous Close: $24.11
  • 50 Day Moving Average: $23.91
  • 200 Day Moving Average: $21.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 19.29
  • P/E Growth: 1.67
  • Market Cap: $32.81B
  • Outstanding Shares: 1,360,743,000
  • Beta: 0.99
Additional Links:
Companies Related to Boston Scientific Corp.:

Analyst Ratings

Consensus Ratings for Boston Scientific Corp. (NYSE:BSX) (?)
Ratings Breakdown: 5 Hold Ratings, 20 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $24.87 (3.16% upside)

Analysts' Ratings History for Boston Scientific Corp. (NYSE:BSX)
DateFirmActionRatingPrice TargetDetails
8/3/2016Citigroup Inc.Boost Price TargetBuy$26.00 -> $28.00View Rating Details
7/31/2016Evercore ISIReiterated RatingBuy$25.50 -> $26.00View Rating Details
7/29/2016RBC Capital MarketsReiterated RatingBuy$28.00View Rating Details
7/29/2016JPMorgan Chase & Co.Boost Price TargetOverweight$24.00 -> $27.00View Rating Details
7/29/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
7/29/2016Leerink SwannReiterated RatingBuyView Rating Details
7/29/2016Jefferies GroupBoost Price TargetHold$21.00 -> $24.00View Rating Details
7/29/2016WedbushBoost Price TargetNeutral$23.00 -> $25.00View Rating Details
7/29/2016Needham & Company LLCBoost Price TargetBuy$26.00 -> $28.00View Rating Details
7/28/2016Benchmark Co.Boost Price TargetBuy$25.00 -> $31.00View Rating Details
6/21/2016Piper Jaffray Cos.Reiterated RatingOverweight$26.00View Rating Details
6/8/2016GuggenheimInitiated CoverageBuy$26.00View Rating Details
5/23/2016BTIG ResearchDowngradeBuy -> Neutral$24.20View Rating Details
5/12/2016Royal Bank Of CanadaReiterated RatingOutperform$25.00View Rating Details
4/28/2016Barclays PLCBoost Price TargetOverweight$23.00 -> $25.00View Rating Details
4/28/2016Stifel NicolausBoost Price TargetBuy$22.00 -> $25.00View Rating Details
4/10/2016ArgusReiterated RatingHoldView Rating Details
4/8/2016Goldman Sachs Group Inc.Boost Price Target$21.00 -> $22.00View Rating Details
3/27/2016Morgan StanleyReiterated RatingOverweight$22.00View Rating Details
3/25/2016Bank of America Corp.Reiterated RatingBuy$23.00View Rating Details
3/18/2016Longbow ResearchInitiated CoverageBuyView Rating Details
3/17/2016NomuraInitiated CoverageBuy$22.00View Rating Details
3/12/2016Deutsche Bank AGReiterated RatingHoldView Rating Details
2/25/2016SunTrust Banks Inc.Initiated CoverageBuy$21.00View Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$21.00 -> $22.50View Rating Details
7/7/2015StephensInitiated CoverageOverweight$21.00View Rating Details
3/20/2015Raymond James Financial Inc.Initiated CoverageOutperform$21.00View Rating Details
3/16/2015BMO Capital MarketsBoost Price TargetOutperform$18.00 -> $19.00View Rating Details
3/3/2015Oppenheimer Holdings Inc.Boost Price TargetMarket Perform$16.00 -> $17.00View Rating Details
2/5/2015JMP SecuritiesBoost Price TargetMarket Outperform$15.00 -> $17.00View Rating Details
2/5/2015CRT CapitalBoost Price TargetBuy$16.00 -> $18.00View Rating Details
(Data available from 8/24/2014 forward)


Earnings History for Boston Scientific Corp. (NYSE:BSX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216$0.27$0.27$2.05 billion$2.13 billionViewListenView Earnings Details
4/27/2016Q116$0.24$0.28$1.91 billion$1.96 billionViewListenView Earnings Details
2/4/2016Q415$0.25$0.26$2.00 billion$1.98 billionViewListenView Earnings Details
10/28/2015Q315$0.23$0.24$1.86 billion$1.89 billionViewListenView Earnings Details
7/23/2015Q215$0.21$0.22$1.83 billion$1.84 billionViewListenView Earnings Details
4/28/2015Q115$0.21$0.21$1.78 billion$1.77 billionViewListenView Earnings Details
2/4/2015Q414$0.21$0.22$1.91 billion$1.89 billionViewListenView Earnings Details
10/22/2014Q314$0.20$0.20$1.82 billion$1.85 billionViewListenView Earnings Details
7/24/2014Q214$0.19$0.18$1.87 billion$1.87 billionViewListenView Earnings Details
4/29/2014Q114$0.18$0.16$1.80 billion$1.77 billionViewListenView Earnings Details
2/4/2014Q4$0.13$0.21$1.83 billion$1.84 billionViewListenView Earnings Details
10/24/2013Q313$0.09$0.17$1.73 billion$1.74 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.10$0.18$1.78 billion$1.81 billionViewListenView Earnings Details
4/25/2013Q1 2013$0.09$0.16$1.79 billion$1.76 billionViewListenView Earnings Details
1/29/2013Q4 2012$0.11$0.18$1.76 billion$1.82 billionViewListenView Earnings Details
10/18/2012$0.11($0.52)ViewN/AView Earnings Details
7/26/2012$0.08$0.17ViewN/AView Earnings Details
4/19/2012$0.13$0.15ViewN/AView Earnings Details
2/2/2012$0.08$0.07ViewN/AView Earnings Details
10/20/2011$0.09$0.15ViewN/AView Earnings Details
7/28/2011$0.08$0.17ViewN/AView Earnings Details
4/20/2011$0.04$0.01ViewN/AView Earnings Details
2/1/2011$0.09$0.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Boston Scientific Corp. (NYSE:BSX)
Current Year EPS Consensus Estimate: $1.1 EPS
Next Year EPS Consensus Estimate: $1.25 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.24$0.24$0.24
Q2 20165$0.26$0.27$0.26
Q3 20164$0.26$0.27$0.27
Q4 20165$0.28$0.29$0.29
Q1 20172$0.30$0.30$0.30
Q2 20172$0.30$0.32$0.31
Q3 20172$0.31$0.32$0.32
Q4 20172$0.33$0.34$0.34
(Data provided by Zacks Investment Research)


Dividend History for Boston Scientific Corp. (NYSE:BSX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Boston Scientific Corp. (NYSE:BSX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2016John Bradley SorensonSVPSell2,500$23.90$59,750.00View SEC Filing  
8/1/2016Michael F MahoneyCEOSell44,400$24.44$1,085,136.00View SEC Filing  
8/1/2016Timothy A PrattEVPSell24,000$24.46$587,040.00View SEC Filing  
7/20/2016David A PierceSVPSell2,480$24.03$59,594.40View SEC Filing  
7/20/2016Michael P. PhalenEVPSell35,000$24.03$841,050.00View SEC Filing  
6/1/2016Michael F MahoneyCEOSell100,000$22.69$2,269,000.00View SEC Filing  
6/1/2016Timothy A PrattEVPSell24,229$22.66$549,029.14View SEC Filing  
5/11/2016John Bradley SorensonSVPSell2,800$22.15$62,020.00View SEC Filing  
5/10/2016Keith D DawkinsEVPSell80,000$22.15$1,772,000.00View SEC Filing  
5/6/2016Jeffrey B MirvissSVPSell24,659$21.94$541,018.46View SEC Filing  
5/3/2016Joseph Michael FitzgeraldEVPSell79,960$21.81$1,743,927.60View SEC Filing  
5/2/2016Michael F MahoneyCEOSell100,000$22.12$2,212,000.00View SEC Filing  
5/2/2016Timothy A PrattEVPSell24,000$21.93$526,320.00View SEC Filing  
4/27/2016Kevin J BallingerSVPSell111,807$21.62$2,417,267.34View SEC Filing  
4/27/2016Timothy A PrattEVPSell39,927$21.40$854,437.80View SEC Filing  
4/4/2016Jeffrey B MirvissSVPSell18,422$19.00$350,018.00View SEC Filing  
4/1/2016Michael F MahoneyCEOSell100,000$18.90$1,890,000.00View SEC Filing  
4/1/2016Timothy A PrattEVPSell24,000$18.73$449,520.00View SEC Filing  
3/11/2016Kevin J BallingerSVPSell16,705$18.00$300,690.00View SEC Filing  
3/8/2016Karen PrangeSVPSell14,747$17.27$254,680.69View SEC Filing  
3/2/2016Michael P. PhalenEVPSell10,665$17.17$183,118.05View SEC Filing  
3/1/2016Michael F MahoneyCEOSell100,000$16.96$1,696,000.00View SEC Filing  
3/1/2016Timothy A PrattEVPSell15,068$16.97$255,703.96View SEC Filing  
2/29/2016Kevin J. BallingerSVPSell2,114$17.17$36,297.38View SEC Filing  
2/29/2016Michael P. PhalenEVPSell1,819$17.19$31,268.61View SEC Filing  
2/25/2016Daniel J BrennanCFOSell103,211$17.22$1,777,293.42View SEC Filing  
2/25/2016Kevin J. BallingerSVPSell1,903$17.48$33,264.44View SEC Filing  
2/25/2016Michael P. PhalenEVPSell34,106$17.28$589,351.68View SEC Filing  
2/17/2016Kevin J. BallingerSVPSell7,616$17.37$132,289.92View SEC Filing  
2/12/2016Charles J DockendorffDirectorBuy30,000$16.49$494,700.00View SEC Filing  
2/8/2016Karen PrangeSVPSell6,216$16.05$99,766.80View SEC Filing  
1/8/2016Timothy A PrattEVPSell7,160$17.67$126,517.20View SEC Filing  
1/7/2016Kevin J BallingerSVPSell19,059$17.73$337,916.07View SEC Filing  
1/5/2016Jeffrey B MirvissSVPSell9,953$18.00$179,154.00View SEC Filing  
12/1/2015Timothy A. PrattEVPSell24,000$18.43$442,320.00View SEC Filing  
11/16/2015Ernest MarioDirectorSell125,000$17.63$2,203,750.00View SEC Filing  
11/9/2015John Bradley SorensonSVPSell4,469$18.68$83,480.92View SEC Filing  
11/9/2015Joseph Michael FitzgeraldEVPSell26,220$18.58$487,167.60View SEC Filing  
11/5/2015Timothy A PrattEVPSell19,598$19.00$372,362.00View SEC Filing  
10/28/2015Jeffrey B MirvissSVPSell9,492$18.00$170,856.00View SEC Filing  
10/28/2015Timothy A PrattEVPSell3,500$18.00$63,000.00View SEC Filing  
10/5/2015Timothy A PrattEVPSell3,500$17.34$60,690.00View SEC Filing  
10/1/2015Timothy A. PrattEVPSell17,000$16.33$277,610.00View SEC Filing  
8/21/2015John E AbeleDirectorBuy200,000$16.77$3,354,000.00View SEC Filing  
8/19/2015John E AbeleDirectorBuy200,000$17.48$3,496,000.00View SEC Filing  
8/17/2015John E AbeleDirectorBuy100,000$17.50$1,750,000.00View SEC Filing  
7/7/2015Karen PrangeSVPSell17,456$17.66$308,272.96View SEC Filing  
5/29/2015Maulik NanavatySVPSell71,558$18.52$1,325,254.16View SEC Filing  
5/28/2015Wendy CarruthersSVPSell42,281$17.91$757,252.71View SEC Filing  
5/18/2015Ernest MarioDirectorSell50,000$18.09$904,500.00View SEC Filing  
5/14/2015John E SununuDirectorSell10,000$17.87$178,700.00View SEC Filing  
5/11/2015John Bradley SorensonSVPSell8,735$17.49$152,775.15View SEC Filing  
3/20/2015David A PierceSVPSell18,050$18.00$324,900.00View SEC Filing  
3/20/2015Michael P PhalenEVPSell46,085$17.94$826,764.90View SEC Filing  
3/16/2015Michael P PhalenEVPSell30,022$17.18$515,777.96View SEC Filing  
3/13/2015John Bradley SorensonSVPSell3,830$16.84$64,497.20View SEC Filing  
3/9/2015David A PierceSVPSell2,561$16.54$42,358.94View SEC Filing  
3/3/2015David A PierceSVPSell8,983$16.79$150,824.57View SEC Filing  
3/3/2015Michael P PhalenEVPSell12,768$16.79$214,374.72View SEC Filing  
2/27/2015David A PierceSVPSell19,046$16.80$319,972.80View SEC Filing  
2/27/2015Michael P PhalenEVPSell1,819$16.80$30,559.20View SEC Filing  
2/19/2015David A PierceSVPSell11,958$16.46$196,828.68View SEC Filing  
2/19/2015Michael P PhalenEVPSell13,188$16.44$216,810.72View SEC Filing  
2/10/2015Joseph Michael FitzgeraldEVPSell61,208$14.66$897,309.28View SEC Filing  
2/9/2015David A PierceSVPSell5,000$14.66$73,300.00View SEC Filing  
2/6/2015Kevin J BallingerSVPSell21,408$15.06$322,404.48View SEC Filing  
1/20/2015Michael P PhalenEVPSell10,000$14.54$145,400.00View SEC Filing  
1/8/2015David A PierceSVPSell18,612$14.31$266,337.72View SEC Filing  
1/8/2015Michael P PhalenEVPSell27,589$14.31$394,798.59View SEC Filing  
1/5/2015Michael P PhalenEVPSell10,000$13.75$137,500.00View SEC Filing  
12/10/2014Karen PrangeSVPSell19,753$12.64$249,677.92View SEC Filing  
12/8/2014David A PierceSVPSell5,000$12.90$64,500.00View SEC Filing  
12/1/2014Ernest MarioDirectorSell10,000$12.96$129,600.00View SEC Filing  
11/28/2014Michael F MahoneyCEOBuy11,700$12.89$150,813.00View SEC Filing  
11/10/2014Edward J LudwigDirectorBuy10,000$13.38$133,800.00View SEC Filing  
11/5/2014John E SununuDirectorSell8,997$13.38$120,379.86View SEC Filing  
11/3/2014Ernest MarioDirectorSell10,000$13.30$133,000.00View SEC Filing  
10/8/2014Ernest MarioDirectorSell10,000$12.06$120,600.00View SEC Filing  
9/2/2014Ernest MarioDirectorSell10,000$12.60$126,000.00View SEC Filing  
8/15/2014Michael P PhalenEVPSell11,471$12.58$144,305.18View SEC Filing  
8/1/2014Ernest MarioDirectorSell10,000$12.58$125,800.00View SEC Filing  
7/30/2014David A PierceSVPSell157$12.97$2,036.29View SEC Filing  
7/15/2014Michael P PhalenEVPSell67,500$13.04$880,200.00View SEC Filing  
7/1/2014Ernest MarioDirectorSell10,000$12.95$129,500.00View SEC Filing  
6/16/2014Michael P PhalenEVPSell13,500$13.02$175,770.00View SEC Filing  
6/2/2014Ernest MarioDirectorSell10,000$12.88$128,800.00View SEC Filing  
5/15/2014Michael PhalenEVPSell13,500$12.76$172,260.00View SEC Filing  
5/1/2014Ernest MarioDirectorSell10,000$12.58$125,800.00View SEC Filing  
4/15/2014Michael PhalenEVPSell13,500$13.25$178,875.00View SEC Filing  
4/1/2014Ernest MarioDirectorSell10,000$13.55$135,500.00View SEC Filing  
3/17/2014Michael PhalenEVPSell13,500$13.05$176,175.00View SEC Filing  
3/6/2014David PierceSVPSell5,316$13.44$71,447.04View SEC Filing  
3/6/2014Michael PhalenEVPSell7,281$13.44$97,856.64View SEC Filing  
2/27/2014David PierceSVPSell2,057$13.29$27,337.53View SEC Filing  
2/27/2014Michael PhalenEVPSell3,166$13.29$42,076.14View SEC Filing  
2/21/2014David PierceSVPSell3,199$13.22$42,290.78View SEC Filing  
2/21/2014Michael PhalenEVPSell3,222$13.22$42,594.84View SEC Filing  
2/18/2014Michael PhalenEVPSell13,500$13.30$179,550.00View SEC Filing  
2/13/2014Kristina JohnsonDirectorSell18,000$13.01$234,180.00View SEC Filing  
2/6/2014Ernest MarioDirectorSell17,104$12.80$218,931.20View SEC Filing  
2/3/2014Ernest MarioDirectorSell10,000$13.19$131,900.00View SEC Filing  
1/6/2014Ernest MarioDirectorSell10,000$12.50$125,000.00View SEC Filing  
12/26/2013Ernest MarioDirectorSell10,000$12.06$120,600.00View SEC Filing  
11/26/2013Jeffrey CapelloCFOSell85,106$11.82$1,005,952.92View SEC Filing  
11/11/2013Jeffrey MirvissSVPSell26,000$11.91$309,660.00View SEC Filing  
8/29/2013Jeffrey CapelloCFOSell525,000$10.68$5,607,000.00View SEC Filing  
8/16/2013Joseph Michael FitzgeraldSVPSell9,202$11.02$101,406.04View SEC Filing  
8/14/2013Kevin BallingerSVPSell38,171$11.28$430,568.88View SEC Filing  
5/31/2013Jeffrey B MirvissSVPSell10,941$9.37$102,517.17View SEC Filing  
5/30/2013Wendy CarruthersSVPSell25,001$9.16$229,009.16View SEC Filing  
5/29/2013Nelda J ConnorsDirectorSell24,116$9.17$221,143.72View SEC Filing  
5/6/2013Ernest MarioDirectorBuy30,000$7.76$232,800.00View SEC Filing  
11/13/2012Nj Nicholas JrDirectorBuy20,000$5.28$105,600.00View SEC Filing  
11/9/2012Nj Nicholas JrDirectorBuy25,000$5.17$129,250.00View SEC Filing  
8/6/2012Ernest MarioDirectorBuy32,000$5.29$169,280.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Boston Scientific Corp. (NYSE:BSX)
DateHeadline logoAnalysts’ Latest Recommendations for Boston Scientific (NYSE:BSX) - August 23 at 4:04 PM logoDelving into BSX’s Category Leadership Growth Strategy (NYSE:BSX) - August 22 at 4:05 PM logoBoston Scientific Corporation (NYSE:BSX) Boasts Rating Of 1.58 - Stocks Daily (NYSE:BSX) - August 21 at 3:49 PM logoBoston Scientific Corporation (NYSE:BSX) Boasts Rating Of 1.58 (NYSE:BSX) - August 20 at 3:59 PM
News IconMedical Appliances & Equipment: Boston Scientific Corporation (NYSE:BSX) Position of the day (NYSE:BSX) - August 20 at 8:56 AM logoMedtronic Plc and Boston Scientific Corporation Poised for Significant Growth in the Global Tumor Ablation Market (NYSE:BSX) - August 19 at 12:21 PM logoDiscussing Boston Scientific’s Expanding Operating Margins (NYSE:BSX) - August 19 at 12:21 PM
News IconHC Stocks in Top Row: Boston Scientific Corporation (NYSE:BSX), Medtronic PLC (NYSE:MDT) - share market updates (press release) (NYSE:BSX) - August 18 at 12:24 PM
News IconLarge Cap Medical Appliances & Equipment: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - August 17 at 4:05 PM
News IconTop Gainers of the Day: Boston Scientific Corporation (NYSE:BSX) from Medical Appliances & Equipment (NYSE:BSX) - August 16 at 9:13 PM logoStocks Buzz: Reynolds American Inc. (RAI) Boston Scientific Corporation (BSX) Under Armour, Inc. (UA) - iStreetWire (NYSE:BSX) - August 16 at 11:20 AM
News IconSVP, Manuf & Sup Chn of Boston Scientific Corporation C (NYSE:BSX), Sorenson John Bradley, sells 2,500 shares worth $59,750 (NYSE:BSX) - August 15 at 4:08 PM logoFDA Approves Boston Scientific's Emblem MRI S-ICD System (NYSE:BSX) - August 15 at 11:12 AM
News IconAnalysts See Compelling Value in Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - August 12 at 12:37 PM
News IconBoston Scientific Corporation (BSX) Shares are Down -0.58% (NYSE:BSX) - August 11 at 4:04 PM
News IconHealthcare Stocks Lure Investment- Boston Scientific (NYSE:BSX), Mylan N.V. (NASDAQ:MYL) - Seneca Globe (NYSE:BSX) - August 11 at 12:10 PM
News IconBoston Scientific Corporation (NYSE:BSX) & Sequenom, Inc. (NASDAQ:SQNM) Stocks are Roundup - Money News (press release) (NYSE:BSX) - August 10 at 9:27 PM logoBOSTON SCIENTIFIC CORP Financials (NYSE:BSX) - August 10 at 3:26 PM logoBoston Scientific Corporation (NYSE:BSX): Updated Analyst Ratings - Review Fortune (NYSE:BSX) - August 10 at 6:31 AM
News IconHC Stocks Watchful: Boston Scientific Corporation (NYSE:BSX), Merck & Co., Inc. (NYSE:MRK) - share market updates (press release) (NYSE:BSX) - August 9 at 10:35 PM
News IconMost Recent Analysts Ratings: Boston Scientific Corporation (NYSE:BSX) - News Oracle (NYSE:BSX) - August 9 at 10:35 PM logoJP Morgan Maintains Boston Scientific Corporation to Overweight with Price Target $27.00 (NYSE:BSX) - August 9 at 5:06 PM logoBRIEF-Boston Scientific gets FDA approval for Emblem MRI system (NYSE:BSX) - August 9 at 12:56 PM
News IconIs Boston Scientific Corporation (NYSE:BSX), a large market cap stock a smart buy? (NYSE:BSX) - August 9 at 12:56 PM
News IconMost Recent Analysts Ratings: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - August 9 at 12:56 PM logoBoston Scientific Adds EMBLEM MRI S-ICD System To Its Growing ImageReady MR-Conditional Devices (NYSE:BSX) - August 9 at 8:16 AM logo[$$] Medicare Requires Some Heart Patients to See a Second Doctor (NYSE:BSX) - August 8 at 9:25 PM
News IconHealthcare Shares Momentum: Eli Lilly and Company (NYSE:LLY ... - TWN (NYSE:BSX) - August 8 at 4:02 PM logoJP Morgan Maintains Boston Scientific Corporation to Overweight with Price Target $27.00 - Trade Calls (NYSE:BSX) - August 8 at 4:02 PM
News IconStocks Showing Trends: Boston Scientific Corporation (NYSE:BSX ... - News Oracle (NYSE:BSX) - August 8 at 4:02 PM
News IconHC Stocks Reports Analysis: Check Cap Ltd (NASDAQ:CHEK) Boston Scientific Corporation (NYSE:BSX) - share market updates (press release) (NYSE:BSX) - August 8 at 8:47 AM
News IconBoston Scientific issues voluntary recall of Lotus valve system (NYSE:BSX) - August 6 at 11:40 AM
News IconTechnical Evaluation For Boston Scientific Corporation (NYSE:BSX) - The Voice Registrar (NYSE:BSX) - August 5 at 4:00 PM logoAnalysts Suggestion Alert: Boston Scientific Corporation (NYSE:BSX) , EnteroMedics Inc. (NASDAQ:ETRM) - Street Updates (NYSE:BSX) - August 5 at 4:00 PM
News IconUpdate on Boston Scientific Corporation (NYSE:BSX) for the day (NYSE:BSX) - August 4 at 4:06 PM logoETF’s with exposure to Boston Scientific Corp. : August 4, 2016 (NYSE:BSX) - August 4 at 4:06 PM logoCalifornia Public Employees Retirement System Sold A Little More Boston Scientific Corporation C (BSX) Stock (NYSE:BSX) - August 3 at 9:40 PM logoBOSTON SCIENTIFIC CORP Files SEC form 10-Q, Quarterly Report (NYSE:BSX) - August 3 at 9:40 PM
News IconLeading stocks in today's market: Boston Scientific Corporation (NYSE:BSX) - Twin County News (NYSE:BSX) - August 3 at 12:41 PM
News IconLeading stocks in today’s market: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - August 2 at 9:39 PM logoBoston Scientific Corp. :BSX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016 (NYSE:BSX) - August 2 at 4:06 PM logoThese 3 Heart Disease Stocks Are Trouncing the S&P 500 This Year (NYSE:BSX) - August 2 at 3:23 PM logoTraders Recap: Boston Scientific Corporation (BSX), Exact Sciences Corporation (EXAS), Pandora Media, Inc. (P) - iStreetWire (NYSE:BSX) - August 2 at 8:47 AM
News IconAnalyst Review: Boston Scientific Corporation (NYSE:BSX) - News Oracle (NYSE:BSX) - August 2 at 8:47 AM
News IconHC Stocks Broker Alerts: Boston Scientific Corporation (NYSE:BSX) Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - share market updates (press release) (NYSE:BSX) - August 1 at 3:57 PM
News IconWhiting Petroleum Corp (NYSE:WLL) & Boston Scientific Corporation (NYSE:BSX) Stocks Trending Alert - Money News (press release) (NYSE:BSX) - August 1 at 3:57 PM logoWhat Analysts Recommend for Boston Scientific after Q2 (NYSE:BSX) - August 1 at 3:57 PM logoAnalysts Update on Stocks: Boston Scientific Corporation (NYSE:BSX) , LifePoint Health, Inc. (NASDAQ:LPNT) - Street Updates (NYSE:BSX) - August 1 at 8:52 AM logoBoston Scientific To Participate In Canaccord Genuity Growth Conference And Wedbush PacGrow Healthcare Conference (NYSE:BSX) - August 1 at 8:30 AM logoAnalysts See Boston Scientific Turnaround Continuing to Run (NYSE:BSX) - July 31 at 10:10 AM


Boston Scientific Corp. (NYSE:BSX) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff